Showing results (161-170 of 882) with videos related to

Sort By:
Pageof 89
Stroke|May 28, 2016
Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated?Laurent Fauchier, Nicolas Clementy, Arnaud Bisson, et al.
Open Heart|December 22, 2015
Cause of death in patients with atrial fibrillation admitted to French hospitals in 2012: a nationwide database studyLaurent Fauchier, Adeline Samson, Gwendoline Chaize, et al.
Cardiovascular Diabetology|October 2, 2025
Testosterone therapy is associated with reduced risk of acute kidney injury, kidney failure with renal replacement therapy, and cardiovascular events in men with diabetes and hypogonadismFabrice Bonnet, Patricia Vaduva, Jean-Michel Halimi, et al.
Cancer|February 25, 2021
Thromboembolism, mortality, and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: A nationwide cohort studyDaniele Pastori, Amélie Marang, Arnaud Bisson, et al.
The American Journal of Cardiology|April 3, 2012
Comparison of frequency of major adverse events in patients with atrial fibrillation receiving bare-metal versus drug-eluting stents in their coronary arteriesLaurent Fauchier, Céline Pellegrin, Anne Bernard, et al.
The American Journal of Cardiology|April 10, 2017
Comparison of Outcome of Possible Versus Definite Infective Endocarditis Involving Native Heart ValvesLauriane Pericart, Anne Bernard, Thierry Bourguignon, et al.
Diabetes & Metabolism|February 3, 2023
Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patientsPierre Henri Ducluzeau, Grégoire Fauchier, Julien Herbert, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 29, 2020
Mortality and cardiac resynchronization therapy with or without defibrillation in primary preventionMatthieu Gras, Arnaud Bisson, Alexandre Bodin, et al.
Presse Medicale (Paris, France : 1983)|May 10, 2011
[When do you implant a pacemaker in myotonic dystrophy?]Dominique Babuty, Bénédicte Lallemand, Valérie Laurent, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 6, 2012
Long-term follow-up on high-rate cut-off programming for implantable cardioverter defibrillators in primary prevention patients with left ventricular systolic dysfunctionNicolas Clementy, Bertrand Pierre, Bénédicte Lallemand, et al.
Pageof 89